This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Solid Pancreatic Mass Lesions or Malignant Neoplasm of Pancreas
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

The goal of this clinical research study is to compare the performance of a newly available needle with reverse bevel design (called the EchoTip® Procore™ needle) with standard needles to see which needle gives better diagnostic information for pancreatic lesions.

Provided treatments

  • Device: Novel 22-gauge Core Biopsy Needle + Standard Biopsy Needle

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01598194. The sponsor of the trial is M.D. Anderson Cancer Center and it is looking for 60 volunteers for the current phase.
Official trial title:
Prospective Comparison of a Novel 22-gauge Core Biopsy Needle With Reverse Bevel Design to a Standard Endoscopic Ultrasound (EUS) Guided Fine Needle Aspiration (FNA) Needle for Diagnosis of Solid Pancreatic Mass Lesions